At the bedside: profiling and treating patients with CXCR4‐expressing cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Leukocyte Biology, 109, 5, S. 953-967
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wo)
-
Weinheim
- (wer)
-
Wiley
- (wann)
-
2021
- Urheber
-
Martin, Miguel
Mayer, Ingrid A.
Walenkamp, Annemiek M. E.
Lapa, Constantin Frederik Victor
Andreeff, Michael
Bobirca, Alexandra
- DOI
-
10.1002/jlb.5bt1219-714r
- URN
-
urn:nbn:de:bvb:384-opus4-813086
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.02.2026, 11:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin, Miguel
- Mayer, Ingrid A.
- Walenkamp, Annemiek M. E.
- Lapa, Constantin Frederik Victor
- Andreeff, Michael
- Bobirca, Alexandra
- Universität Augsburg
- Wiley
Entstanden
- 2021
Ähnliche Objekte (12)
![Cancer immunology, [...]. Bench to bedside immunotherapy of cancers](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Cancer immunology, [...]. Bench to bedside immunotherapy of cancers
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
Treating solid cancers with a new strategy
Traditional Chinese medicine in treating upper digestive tract cancers
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
PD-L1 expressing circulating tumour cells in head and neck cancers
Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance
The healthcare costs of treating human papillomavirus-related cancers in Norway
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
The bedside Esquire
Bed-Side - Schriftwechsel
Cancer immunology, [...]. Bench to bedside immunotherapy of cancers
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
Treating solid cancers with a new strategy
Traditional Chinese medicine in treating upper digestive tract cancers
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
PD-L1 expressing circulating tumour cells in head and neck cancers
Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance
The healthcare costs of treating human papillomavirus-related cancers in Norway
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
The bedside Esquire
Bed-Side - Schriftwechsel
Cancer immunology, [...]. Bench to bedside immunotherapy of cancers
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
Treating solid cancers with a new strategy
Traditional Chinese medicine in treating upper digestive tract cancers
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
PD-L1 expressing circulating tumour cells in head and neck cancers
Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance
The healthcare costs of treating human papillomavirus-related cancers in Norway
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
The bedside Esquire